the aid library

LIST OPTIONS

Filter

8658

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (522)

View PDF (944)

Key considerations: the context of North Kivu province, DRC

Social Science in Humanitarian Action: A Communication for Development Platform (2018) C1

This brief focuses specifically on the Grand Nord (Great North): the Beni and Lubero territories of northern North Kivu that are the epicentre of the outbreak. Further participatory enquiry should be undertaken with the affected populations, but given ongoing transmission, conveying key consideratio... more

Download (282)

View PDF (383)

Understanding refugee trauma: for mental health professionals
recommended

The National Child Traumatic Stress Network NCTSN (2007) C1

Refugee children and adolescents exhibit resilience despite a history of trauma. However, trauma can affect a refugee child’s emotional and behavioral development. Mental health providers should consider how the refugee experience (e.g., exposure to hunger, thirst, and lack of shelter; injury an... more

Download (349)

View PDF (488)

South Sudan Health Cluster Bulletin 12, December 2018

World Health Organization, Health Cluster (2019) C_WHO

Emergency WASH in Health Facilities in Conflict Affected Locations 756 health workers trained on disease surveillance and outbreak response. Around 142 health workers trained on integrated health (WASH and Nutrition) response. 405 health facilities are equipped with functional incinerators. Qual... more

Download (239)

View PDF (284)

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
recommended

World Health Organization WHO (2021) C_WHO

23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health... more

Download (274)

View PDF (274)

Human African trypanosomiasis. Seminar

Büscher P., Cecchi G., Jamonneau V. et al (2017) C2

The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017. Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ... more

Download (129)

View PDF (136)

CVD and the Development Agenda: Advocacy Toolkit

World Heart Federation (2017) CC

Global Development: Where Are We Now? Today, we are facing a vital opportunity to change the profile of cardiovascular disease around the world. The Millennium Development Goals (MDGs) are due to expire at the end of 2015, placing the cardiovascular health community in a unique position to shape t... more

Download (502)

View PDF (682)

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended

World Health Organization WHO (2021) C_WHO

Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident... more

Download (309)

View PDF (352)

Management of febrile seizures

World Health Organization WHO (2012) C_WHO

Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo... more

Download (831)

View PDF (1402)

A practical handbook on the pharmacovigilance of antiretroviral medicines

World Health Organization WHO (2013) C_WHO

This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica... more

External Link

Rooted in Trust: Mali Rumor Bulletins

Internews (2021) CC

Internews’ Rooted In Trust (RiT) Project tracks COVID-19-related rumors circulating among social media users and vulnerable communities in Mali, as well as other countries around the globe. The rumors are used to inform risk communication efforts by humanitarians and public health actors, and to s... more

Download (237)

View PDF (618)

Strengthening capacity for noncommunicable disease implementation research in the WHO European Region (2019)

World Health Organization WHO, Regional Office of Europe (2019) C_WHO

Calls for greater implementation research (IR) capacity came in the wake of compelling evidence that implementation strategies are critically important for the dissemination and facilitation of evidence-informed policies and interventions to tackle noncommunicable diseases (NCDs), thereby improving ... more

Download (244)

View PDF (359)

Fiscal Space for Health in Latin America and the Caribbean

Pan American Health Organization (PAHO) Pan American Health Organization (PAHO) (2020) CC

In sum, the goal is to understand the need to increase fiscal space for health as a prerequisite, but within the framework of efforts to transform the health system. These changes should foster equitable and efficient expenditures and create or strengthen comprehensive integrated health systems with... more

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Senegal

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr... more

Download (601)

View PDF (641)

GUIDELINES FOR GOOD CLINICAL LABORATORY PRACTICES (GCLP)

Indian Council of Medical Research (ICMR) (2008) C1

Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health research and patient treatment. As the use of laboratory... more

External Link

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries

Torres-Rueda S.; S. Sweeney; F. Bozzani et al. BMJ Global Health (2021) C2

COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di... more

Download (1461)

View PDF (2633)

Good Pharmacy Practice - Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services

World Health Organization (WHO), International Pharmaceutical Federation (FIP) (2011) C_WHO

WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na... more

Download (281)

View PDF (405)

The Core Elements of Hospital Antibiotic Stewardship Programs: 2019

Centers for Disease Control and Prevention CDC (2019) C_CDC

This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti... more

Download (125)

View PDF (229)

Essential Health Services Package for UHC Sierra Leone

Ministry of Health & Sanitation (2022) CC2

It is against this background that the Ministry of Health and Sanitation with its partners have taken the lead to develop Essential Health Services Package (EHSP). The MOHS believes that the development of EHSP; defining the services that should be available at each level of care (community to ... more

Download (122)

View PDF (240)

Capacity building in public health nutrition

Geissler, C. Proceedings of the Nutrition Society (2015) CC

The aim of the present paper is to review capacity building in public health nutrition (PHN), the need for which has been stressed for many years by a range of academics, national and international organisations. Although great strides have been made worldwide in the science of nutrition, there rema... more

Understanding refugee trauma: for mental health professionals recommended

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 recommended

Understanding refugee trauma: for mental health professionals
recommended

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended